Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

What an exciting time to be a shareholder. Actually, the two upcoming conference presentations are going to have a much different feel and affect than in the past...

1) as the Eltoprazine launch is most likely imminent. What to watch for is if they got any non dilutive funding for the trial (a MJFF sponsorship or anyone else will double the stock price).

2) Secondly, the latest LymPro data release could have a significant impact; if they were able to increase the specificity and sensitivity back above 90%. Any Pre-announced revenue will light a fire under the stock price too.

3) Thirdly, there are promised near term catalysts coming as to what other Diagnostic assets were acquired and what potential spin out can occur with LymPro as well (and if there are any hints on timing of the Up list).

4) MANF - what is next? I think their will be a surprise factor here...so many possible (3rd parties) could be attracted to this asset. We have not heard much about the Parkinsons program either.

Amarantus has grown up; but is it capable of taking a leap and catapulting its credibility (with delivering the goods). Historically, I cant imagine a more critical time and juncture in the company's history than what could happen this week. Its showtime folks!!! GLTA!!!